Next generation autoinjectors: balancing Patient, Pharma, Payers and Planet
Our team use a reusable autoinjector case study to outline the product development approach needed to improve outcomes for patients, pharma, payers and the planet.
How digital twin innovation can accelerate healthcare product development
Deep tech consultants explore the challenges and rewards of implementing a digital twin prototype to accelerate healthcare product development
From stealth mode to the shock of the new – how deep tech can boost company valuation
Why is deep tech important? What defines deep tech, and how to value deep tech companies? With stealth and surprise, deep tech can boost company valuation.
Generative biology breakthrough from Capgemini – PharmaTimes
Capgemini announced on Monday that it had made a breakthrough in generative biology, also known as engineering or synthetic biology, at its deep tech powerhouse Cambridge Consultants. The news was been widely picked up, including by PharmaTimes
Capgemini reveals gen AI-driven breakthrough to accelerate the bioeconomy
Capgemini’s new patent-pending generative AI uses specialized large language models to accelerate the bioeconomy and biotechnology sector by drastically reducing the time and resources needed for research and development.
What is deep tech? A strategy to create value from an enduring, defensible competitive advantage
What is deep tech? When discussing deep tech meaning, deep tech consultants Cambridge Consultants define it as a strategy for value and commercial advantage.